Motion to Read a Third Time and Pass
Yes
33
Absent
2
SB425 Alabama 2019 Session
Updated Apr 26, 2021
SB425 Alabama 2019 Session
Senate Bill
Enacted
Current Status
Regular Session 2019
Session
1
Sponsor
Summary
- Primary Sponsor
-
Larry Stutts SenatorRepublican - Session
- Regular Session 2019
- Title
- Health care, treatment guidelines relating to buprenorphine, review committee established to aid in rule drafting
- Description
This bill would establish guidelines for the use of buprenorphine in nonresidential treatment programs.
This bill would also provide for the adoption of rules to further implement and enforce the provisions of the act.
- Subjects
- Health
Bill Actions
S
Assigned Act No. 2019-500.
H
Signature Requested
S
Enrolled
S
Passed Second House
H
Motion to Read a Third Time and Pass adopted Roll Call 1282
H
Third Reading Passed
H
Read for the second time and placed on the calendar
H
Read for the first time and referred to the House of Representatives committee on Health
S
Motion to Read a Third Time and Pass adopted Roll Call 1237
S
Third Reading Passed
S
Read for the second time and placed on the calendar
S
Read for the first time and referred to the Senate committee on Finance and Taxation General Fund
Bill Text
Loading PDF...
Votes
Motion to Read a Third Time and Pass
Yes
92
Abstained
2
Absent
10
Documents
Bill Text (Enrolled)
SB425 Alabama 2019 Session - Enrolled
Bill Text (Introduced)
SB425 Alabama 2019 Session - Introduced
Source: Alabama Legislature